Efalizumab (brand name Raptiva) is a formerly available medication designed to treat autoimmune diseases, originally marketed to treat psoriasis. It is a recombinant humanized monoclonal antibody administered once weekly by subcutaneous injection.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.